Bruno Salaun

6PUBLICATIONS
43CO-AUTHORS
Pacific Peoples life courseInnate immunityInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 05, 2026
Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years.

|Aug 18, 2021
Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.

Edward A Stadtmauer, Keith M Sullivan, Mohamed El Idrissi

|Jul 21, 2021
Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study.

Joon Hyung Kim, Mamadou Drame, Thanyawee Puthanakit

|Jun 30, 2021
Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview.

Alemnew F Dagnew, Peter Vink, Mamadou Drame

|Sep 05, 2020
Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system.

Damien Friel, Mary Co, Thierry Ollinger

|Dec 17, 2019
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts.

Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer

Pageof 1

Frequent Collaborators

4 joint publications

Anne Schuind

3 joint publications

Damien Friel

2 joint publications

Alemnew F Dagnew

2 joint publications

David W Vaughn